Business Context and Reporting Period
Chimera Investment Corporation filed a Form 8-K on June 23, 2010, reporting the entry into a material definitive agreement. The company is a Maryland corporation with principal executive offices in New York, New York.
Key Financial Metrics
This filing details a capital raise rather than operational performance metrics. The company entered into an underwriting agreement for the sale of 100,000,000 shares of Common Stock, par value $0.01 per share. An over-allotment option for an additional 15,000,000 shares was granted to the Underwriters.
- Estimated Net Proceeds: Approximately $360.8 million (excluding potential over-allotment proceeds and after deducting estimated expenses).
- Closing Date: Expected on June 28, 2010.
- Underwriters: Credit Suisse Securities (USA) LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, and RCap Securities, Inc.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity as this is a transactional report.
Material Changes
The primary material change is the execution of the underwriting agreement for the Public Offering. This represents a significant increase in the company's capital base pending the closing of the transaction.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the offering and the expected closing date. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard terms of the underwriting agreement.
Investor Verification Checklist
- Verify the final closing date of the Public Offering (expected June 28, 2010).
- Confirm the final net proceeds received after the deduction of all offering expenses.
- Determine if the underwriters exercised the 15,000,000 share over-allotment option.
- Review the use of proceeds disclosed in subsequent filings to ensure alignment with the company's investment strategy.